Belgian pharmaceuticals giant Solvay posts profit rise

July 27, 2012

Belgium's pharmaceuticals giant Solvay announced a better-than-expected 6.0 percent rise in net profit for the second quarter on Friday, sending its shares rising sharply.

Shortly after the opening of trade in Brussels, shares in Solvay showed a 6.94 percent rise to 87.12 euros after the announcement of the results, which show the company on track to do as well in 2012 as the previous year.

Solvay said that despite the in demand in the sector in June, cuts and restructuring would enable it to do as well as in 2011.

The group reported adjusted of 244 million euros from April to June.

Related Stories

Recommended for you

Sustaining biomedical research: Med school deans speak out

May 27, 2015

Cuts in federal support and unreliable funding streams are creating a hostile work environment for scientists, jeopardizing the future of research efforts and ultimately clinical medicine, according to leaders of the nation's ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.